STOK Stock Analysis: Buy, Sell, or Hold?
STOK - Stoke Therapeutics, Inc. Common Stock
$32.29
0.89 (2.83%)
▲
5d:
+3.26%
30d:
+8.9%
90d:
+8.83%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Get Alerted When STOK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: STOK shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: STOK shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: STOK is currently trading at $32.29, which is considered extended relative to its 30-day fair value range of $28.94 to $32.04.
Technical Outlook: Technically, STOK is in a strong uptrend. Immediate support is located at $29.86, while resistance sits at $33.56.
Market Sentiment: STOK scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $47.00 (+46.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STOK is in a strong uptrend. Immediate support is located at $29.86, while resistance sits at $33.56.
Market Sentiment: STOK scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $47.00 (+46.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.94 -
$32.04
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.3%
Protect Your Profits
Holding STOK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (37/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.3% below Wall St target ($47.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$28.94 -
$32.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$29.86
Resistance Level
$33.56
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.19
Wall Street Target
$47.00
(+46.3%)
Revenue Growth (YoY)
-32.5%
Share & Embed Analysis
Last updated: August 23, 2026 3:40 AM ET
Data refreshes hourly during market hours. Next update: 4:40 AM
Data refreshes hourly during market hours. Next update: 4:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STOK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Barry Ticho
SELL
1461 shares
2026-03-19
Thomas Leggett
SELL
2382 shares
2026-03-18
Jonathan Allan
SELL
4628 shares
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 40 SELL |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 42 HOLD |
Advanced STOK Option Strategies
Professional options setups generated by AI based on today's STOK price and gamma walls.
